acrolein has been researched along with Fatty Liver, Nonalcoholic in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 3 (100.00) | 2.80 |
Authors | Studies |
---|---|
Dang, Y; Ji, G; Pan, J; Tang, Y; Xiao, X; Xu, R; Zhang, S; Zhou, W | 1 |
Cao, S; Chen, W; Liu, W; Qiu, W; Shi, D; Wang, B; Yu, L | 1 |
Ai, J; Gai, H; Huang, W; You, Y; Zhan, J; Zhang, Y; Zhou, F | 1 |
3 other study(ies) available for acrolein and Fatty Liver, Nonalcoholic
Article | Year |
---|---|
The methyltransferase METTL3-mediated fatty acid metabolism revealed the mechanism of cinnamaldehyde on alleviating steatosis.
Topics: Acrolein; Animals; Arachidonic Acids; Fatty Acids, Nonesterified; gamma-Linolenic Acid; Methyltransferases; Mice; Non-alcoholic Fatty Liver Disease; Triglycerides | 2022 |
Single-chemical and mixture effects of multiple volatile organic compounds exposure on liver injury and risk of non-alcoholic fatty liver disease in a representative general adult population.
Topics: Acrolein; Acrylamides; Acrylonitrile; Adult; Bayes Theorem; Biomarkers; Cross-Sectional Studies; Dimethylformamide; Humans; Non-alcoholic Fatty Liver Disease; Nutrition Surveys; Styrenes; Toluene; United States; Volatile Organic Compounds; Xylenes | 2023 |
Coniferaldehyde ameliorates the lipid and glucose metabolism in palmitic acid-induced HepG2 cells via the LKB1/AMPK signaling pathway.
Topics: Acrolein; AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Glucose; Hep G2 Cells; Humans; Lipid Metabolism; Lipogenesis; Non-alcoholic Fatty Liver Disease; Palmitic Acid; Protein Serine-Threonine Kinases; Signal Transduction; Sterol Regulatory Element Binding Protein 1; Triglycerides | 2020 |